SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-22-000012
Filing Date
2022-01-05
Accepted
2022-01-05 19:03:23
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164142738024738.html 4  
1 FORM 4 wf-form4_164142738024738.xml 4 3801
2 PIEPER, STEVEN M POA ex-24.htm EX-24 3001
  Complete submission text file 0001867096-22-000012.txt   8196
Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address XERIS PHARMACEUTICALS, INC. 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address
Pieper Steven (Reporting) CIK: 0001875714 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 22513022